Nektar Therapeutics (NKTR) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free NKTR Stock Alerts $1.32 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Nektar Therapeutics Short Interest DataCurrent Short Volume3,110,000 sharesPrevious Short Volume2,360,000 sharesChange Vs. Previous Month+31.78%Dollar Volume Sold Short$4.88 millionShort Interest Ratio / Days to Cover1.3Last Record DateApril 15, 2024Outstanding Shares183,620,000 sharesFloat Size177,940,000 sharesShort Percent of Float1.75%Today's Trading Volume559,095 sharesAverage Trading Volume3,688,850 sharesToday's Volume Vs. Average15% Short Selling Nektar Therapeutics ? Sign up to receive the latest short interest report for Nektar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNKTR Short Interest Over TimeNKTR Days to Cover Over TimeNKTR Percentage of Float Shorted Over Time Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Nektar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,110,000 shares $4.88 million +31.8%1.8%1.3 $1.57 3/31/20242,360,000 shares $2.20 million -6.0%1.3%1.2 $0.93 3/15/20242,510,000 shares $2.16 million +24.9%1.4%1.6 $0.86 2/29/20242,010,000 shares $1.43 million -18.0%1.1%1.2 $0.71 2/15/20242,450,000 shares $1.81 million -57.8%N/A2 $0.74 1/31/20245,800,000 shares $3.15 million +6.6%N/A4.8 $0.54 Get the Latest News and Ratings for NKTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,440,000 shares $2.91 million +1.7%N/A3.7 $0.53 12/31/20235,350,000 shares $3.02 million -23.1%N/A3.4 $0.57 12/15/20236,960,000 shares $3.26 million -3.7%N/A4.5 $0.47 11/30/20237,230,000 shares $3.54 million -9.7%N/A4.6 $0.49 11/15/20238,010,000 shares $4.21 million +7.2%N/A4.7 $0.53 10/31/20237,470,000 shares $3.50 million -8.8%N/A2.8 $0.47 10/15/20238,190,000 shares $4.41 million +5.8%N/A1.4 $0.54 9/30/20237,740,000 shares $4.61 million +6.6%N/A1.3 $0.60 9/15/20237,260,000 shares $5.12 million +7.1%N/A1.2 $0.71 8/31/20236,780,000 shares $4.03 million -5.2%N/A1 $0.60 8/15/20237,150,000 shares $5.79 million +23.3%N/A1 $0.81 7/31/20235,800,000 shares $3.11 million +9.9%N/A0.9 $0.54 7/15/20235,280,000 shares $2.90 million -2.8%N/A1.5 $0.55 6/30/20235,430,000 shares $3.12 million -50.8%N/A1.4 $0.58 6/15/202311,030,000 shares $6.23 million +11.5%N/A2 $0.56 5/31/20239,890,000 shares $5.74 million -2.1%N/A2 $0.58 5/15/202310,100,000 shares $7.71 million +5.4%N/A2 $0.76 4/30/20239,580,000 shares $7.21 million +16.7%5.8%2 $0.75 4/15/20238,210,000 shares $7.60 million -3.5%N/A1.7 $0.93 3/31/20238,510,000 shares $5.98 million +20.2%N/A1.9 $0.70 3/15/20237,080,000 shares $8.07 million -19.1%N/A2.9 $1.14 2/28/20238,750,000 shares $12.08 million -11.8%N/A4.5 $1.38 2/15/20239,920,000 shares $30.85 million -0.1%N/A4.9 $3.11 1/31/20239,930,000 shares $27.01 million +7.7%N/A6.1 $2.72 1/15/20239,220,000 shares $23.23 million +2.4%N/A5.9 $2.52 12/30/20229,000,000 shares $20.34 million -1.6%N/A5.6 $2.26 12/15/20229,150,000 shares $24.71 million -44.4%N/A5.3 $2.70 11/30/202216,470,000 shares $46.12 million -1.9%N/A9 $2.80 11/15/202216,790,000 shares $65.82 million -3.2%N/A10.6 $3.92 10/31/202217,350,000 shares $65.24 million -0.2%N/A10.6 $3.76 10/15/202217,390,000 shares $61.73 million -0.6%N/A9.5 $3.55 9/30/202217,500,000 shares $56 million -0.5%N/A7.7 $3.20 9/15/202217,590,000 shares $64.38 million -0.2%N/A6.5 $3.66 8/31/202217,630,000 shares $69.46 million -6.5%N/A6.1 $3.94Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details NKTR Short Interest - Frequently Asked Questions What is Nektar Therapeutics' current short interest? Short interest is the volume of Nektar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 3,110,000 shares of NKTR short. 1.75% of Nektar Therapeutics' shares are currently sold short. Learn More on Nektar Therapeutics' current short interest. What is a good short interest ratio for Nektar Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NKTR shares currently have a short interest ratio of 1.0. Learn More on Nektar Therapeutics's short interest ratio. What is a good short interest percentage for Nektar Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.75% of Nektar Therapeutics' floating shares are currently sold short. Is Nektar Therapeutics' short interest increasing or decreasing? Nektar Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,110,000 shares, an increase of 31.8% from the previous total of 2,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nektar Therapeutics' float size? Nektar Therapeutics currently has issued a total of 183,620,000 shares. Some of Nektar Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nektar Therapeutics currently has a public float of 177,940,000 shares. How does Nektar Therapeutics' short interest compare to its competitors? 1.75% of Nektar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nektar Therapeutics: Atea Pharmaceuticals, Inc. (2.37%), Omeros Co. (23.62%), Seres Therapeutics, Inc. (11.67%), ADC Therapeutics SA (1.60%), Assembly Biosciences, Inc. (0.84%), Pyxis Oncology, Inc. (4.78%), Xeris Biopharma Holdings, Inc. (6.03%), Inozyme Pharma, Inc. (7.66%), XBiotech Inc. (3.40%), Nanobiotix S.A. (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Nektar Therapeutics stock? Short selling NKTR is an investing strategy that aims to generate trading profit from Nektar Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nektar Therapeutics? A short squeeze for Nektar Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NKTR, which in turn drives the price of the stock up even further. How often is Nektar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NKTR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: AVIR Short Interest OMER Short Interest MCRB Short Interest ADCT Short Interest ASMB Short Interest PYXS Short Interest XERS Short Interest INZY Short Interest XBIT Short Interest NBTX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NKTR) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingUrgent Nvidia WarningAltimetryHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm Press